AbbVie | ABBV

AbbVie traded at $155.30 this Thursday March 16th, increasing $1.24 or 0.80 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 2.64 percent. Over the last 12 months, its price fell by 2.07 percent. Looking ahead, we forecast AbbVie to be priced at 144.93 by the end of this quarter and at 131.50 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
155.30
Daily Change
0.80%
Yearly
-2.07%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Eisai 7,512.00 137.00 1.86% 28.23%
AbbVie 155.30 1.24 0.80% -2.07%
Abbott 99.03 1.23 1.26% -18.29%
ALKERMES 26.68 0.06 0.23% 3.05%
Amgen 234.57 -0.33 -0.14% -0.55%
AstraZeneca 10,834.00 36.00 0.33% 13.61%
AstraZeneca 65.98 1.40 2.17% 3.63%
Biogen 265.25 2.88 1.10% 29.19%
BioMarin Pharmaceutical 93.41 5.67 6.46% 16.36%
Bristol-Myers Squibb 67.10 -0.38 -0.56% -4.85%
Coherus Biosciences 6.37 -0.02 -0.31% -50.39%
Endo International 0.08 -0.003 -3.13% -96.72%
Gilead Sciences 79.85 0.20 0.25% 34.38%
GlaxoSmithKline 1,406.00 19.00 1.37% -12.67%
Horizon Pharma 109.58 0.11 0.10% 3.00%
Intercept Pharmaceuticals 15.81 0.25 1.61% -2.83%
Infinity Pharmaceuticals 0.20 0.02 8.73% -81.14%
Jazz Pharmaceuticals 137.22 2.33 1.73% -12.86%
J&J 154.03 -0.32 -0.21% -12.88%
Eli Lilly 329.53 0.06 0.02% 14.56%
Medtronic 79.27 0.86 1.10% -28.05%
Merck & Co 107.34 -0.29 -0.27% 35.98%
Neurocrine Biosciences 94.25 0.14 0.15% 0.61%
Novartis 77.02 0.03 0.04% -4.65%
Pacira 41.47 2.11 5.36% -43.49%
Pfizer 40.37 0.09 0.22% -25.57%
Perrigo 35.69 0.10 0.28% -7.37%
Ultragenyx Pharmaceutical 40.22 -0.51 -1.25% -41.59%
Regeneron Pharmaceuticals 749.75 -10.55 -1.39% 9.30%
Roche Holding 262.40 1.10 0.42% -28.40%
Revance Therapeutics 31.15 0.50 1.63% 80.27%
Sanofi 90.26 0.03 0.03% -3.25%
Teva Pharmaceutical Industries 8.50 -0.17 -1.96% 7.87%
UCB 79.32 0 0% -24.49%
United Therapeutics 220.05 2.55 1.17% 19.27%
Vertex Pharmaceuticals 300.64 6.37 2.16% 20.70%
Zoetis 166.31 2.74 1.68% -14.13%

Indexes Price Day Year
US500 3934 68.35 1.76% -11.87%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.